Please assess the completion status of the following clinical trial:

Trial Title: Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Successful completion of the 3001B3-331 study (NCT00362609) or 3001B3-333 study (NCT00259012) Study.~Exclusion Criteria:~* Patients requiring chronic use of warfarin, carbamepazine, or phenytoin.

- Gender: ALL
- Minimum Age: 1 Day
- Maximum Age: 12 Months
- Healthy Volunteers: f

Study Arms:
- Low dose (Type: ACTIVE_COMPARATOR): None
- High dose (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).